22157.jpg
mRNA Therapeutics and Vaccines Market, 2030
March 25, 2021 06:03 ET | Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics and Vaccines Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The "mRNA Therapeutics and Vaccines...
22157.jpg
United States Vaccine Vials (Multi Dose and Single Dose) Market Report 2021-2025: Type, Material, Capacity, Application - Cumulative Impact of COVID-19
February 11, 2021 07:28 ET | Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Vaccine Vials Market Research Report by Type (Multi Dose and Single Dose), by Material (Glass and Polymer), by Capacity, by Application - United States...
22157.jpg
COVID-19 Vaccine & Therapeutics Clinical Trial Analysis Report 2020
November 18, 2020 03:13 ET | Research and Markets
Dublin, Nov. 18, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020" report has been added to ResearchAndMarkets.com's offering. Major players in the...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines Announces Third Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM Patients
February 07, 2019 08:00 ET | VBI Vaccines, Inc.
Independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of the study without modificationEnrollment is complete in the high-dose study arm of Part AExpanded immunologic...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017
November 10, 2017 08:00 ET | VBI Vaccines, Inc.
New data confirms use of intradermal delivery of eVLPs may be a potent “off-the-shelf” immunotherapy vaccinePoster presentation at the Society for Immunotherapy of Cancer’s (SITC) 32nd Annual Meeting...
Bionor Pharma's Phase II Vacc-4x Data Published in the Lancet Infectious Diseases
February 11, 2014 09:27 ET | Bionor Pharma
OSLO, NORWAY--(Marketwired - Feb 11, 2014) - Bionor Pharma ASA (OSE: BIONOR) announces that the results from the randomized, multicenter, double-blinded, placebo-controlled Phase II trial with 135...
Successful Immunization and Safety Documented in Nasal Administration Study of the HIV Vaccine Vacc-4x Together With Endocine
May 10, 2012 06:47 ET | Bionor Pharma
OSLO, NORWAY--(Marketwire - May 10, 2012) - Bionor Pharma (OSLO: BIONOR) News Summary Vaccine related immune responses found in HIV patients given Vacc-4x...
NAPWA, TAEP to Urge Congress to Implement Healthcare Reform, End Federal Bans Targeting HIV-Positive Americans at AIDSWatch 2012
April 19, 2012 08:00 ET | National Association of People with AIDS
WASHINGTON, DC--(Marketwire - Apr 19, 2012) - Today the National Association of People with AIDS (NAPWA) and the Treatment Access Expansion Project (TAEP) announces AIDSWatch 2012, the largest...
VIRxSYS Issued U.S. Patents for Its Lentiviral Vector and SMaRT RNA Platforms
November 15, 2011 09:10 ET | VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Nov 15, 2011) - VIRxSYS Corporation, a Maryland-based biotechnology company, today announced that the United States Patent and Trademark Office has issued two...
New HIV Research Findings to Be Presented at NAPWA "Treatment Horizons: Pathways to a Functional Cure" Satellite Symposium, International AIDS Society, Rome
July 15, 2011 07:30 ET | National Association of People with AIDS
SILVER SPRING, MD and ROME--(Marketwire - Jul 15, 2011) - HIV researchers working towards developing potential functional cures from three continents will present new data that collectively light a...